534 related articles for article (PubMed ID: 15824924)
1. Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles.
Kalayda GV; Jansen BA; Wielaard P; Tanke HJ; Reedijk J
J Biol Inorg Chem; 2005 May; 10(3):305-15. PubMed ID: 15824924
[TBL] [Abstract][Full Text] [Related]
2. Dinuclear platinum complexes with N, N'-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part I. Synthesis, cytotoxicity, and cellular studies in A2780 human ovarian carcinoma cells.
Jansen BA; Wielaard P; Kalayda GV; Ferrari M; Molenaar C; Tanke HJ; Brouwer J; Reedijk J
J Biol Inorg Chem; 2004 Jun; 9(4):403-13. PubMed ID: 15071767
[TBL] [Abstract][Full Text] [Related]
3. Dinuclear platinum complexes with N, N'-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part II. Cellular processing in A2780 cisplatin-resistant human ovarian carcinoma cells: new insights into the mechanism of resistance.
Kalayda GV; Jansen BA; Molenaar C; Wielaard P; Tanke HJ; Reedijk J
J Biol Inorg Chem; 2004 Jun; 9(4):414-22. PubMed ID: 15071768
[TBL] [Abstract][Full Text] [Related]
4. Application of fluorescence microscopy for investigation of cellular distribution of dinuclear platinum anticancer drugs.
Kalayda GV; Zhang G; Abraham T; Tanke HJ; Reedijk J
J Med Chem; 2005 Aug; 48(16):5191-202. PubMed ID: 16078838
[TBL] [Abstract][Full Text] [Related]
5. A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system.
Perego P; Caserini C; Gatti L; Carenini N; Romanelli S; Supino R; Colangelo D; Viano I; Leone R; Spinelli S; Pezzoni G; Manzotti C; Farrell N; Zunino F
Mol Pharmacol; 1999 Mar; 55(3):528-34. PubMed ID: 10051537
[TBL] [Abstract][Full Text] [Related]
6. Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status.
Martelli L; Di Mario F; Botti P; Ragazzi E; Martelli M; Kelland L
Biochem Pharmacol; 2007 Jun; 74(1):20-7. PubMed ID: 17466278
[TBL] [Abstract][Full Text] [Related]
7. New insights in the cellular processing of platinum antitumor compounds, using fluorophore-labeled platinum complexes and digital fluorescence microscopy.
Molenaar C; Teuben JM; Heetebrij RJ; Tanke HJ; Reedijk J
J Biol Inorg Chem; 2000 Oct; 5(5):655-65. PubMed ID: 11085656
[TBL] [Abstract][Full Text] [Related]
8. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
Garmann D; Warnecke A; Kalayda GV; Kratz F; Jaehde U
J Control Release; 2008 Oct; 131(2):100-6. PubMed ID: 18691617
[TBL] [Abstract][Full Text] [Related]
9. The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells.
Perego P; Gatti L; Caserini C; Supino R; Colangelo D; Leone R; Spinelli S; Farrell N; Zunino F
J Inorg Biochem; 1999 Oct; 77(1-2):59-64. PubMed ID: 10626355
[TBL] [Abstract][Full Text] [Related]
10. Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs.
Jansen BA; Brouwer J; Reedijk J
J Inorg Biochem; 2002 Apr; 89(3-4):197-202. PubMed ID: 12062123
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity and cellular processing in human ovarian carcinoma cell lines of a new platinum(II) compound containing a fluorescent substituted propylene diamine ligand.
Marqués-Gallego P; den Dulk H; Brouwer J; Tanase S; Mutikainen I; Turpeinen U; Reedijk J
Biochem Pharmacol; 2009 Aug; 78(4):365-73. PubMed ID: 19413998
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and SAR studies of novel 1,2-bis(aminomethyl)cyclohexane platinum(II) complexes with cytotoxic activity. Studies of interaction with DNA of iodinated seven-membered 1,4-diaminoplatinocycles.
Gay M; Montaña ÁM; Batalla C; Mesas JM; Alegre MT
J Inorg Biochem; 2015 Jan; 142():15-27. PubMed ID: 25305632
[TBL] [Abstract][Full Text] [Related]
13. Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
Marqués-Gallego P; Kalayda GV; Jaehde U; Dulk Hd; Brouwer J; Reedijk J
J Inorg Biochem; 2009 May; 103(5):791-6. PubMed ID: 19303143
[TBL] [Abstract][Full Text] [Related]
14. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
[TBL] [Abstract][Full Text] [Related]
15. Palladium(II) and platinum(II) bis(thiosemicarbazone) complexes of the 2,6-diacetylpyridine series with high cytotoxic activity in cisplatin resistant A2780cisR tumor cells and reduced toxicity.
Matesanz AI; Leitao I; Souza P
J Inorg Biochem; 2013 Aug; 125():26-31. PubMed ID: 23685347
[TBL] [Abstract][Full Text] [Related]
16. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
[TBL] [Abstract][Full Text] [Related]
17. New palladium and platinum complexes with bioactive 3,5-diacetyl-1,2,4-triazol bis(4-cyclohexyl thiosemicarbazone) ligand: chemistry, antiproliferative activity and preliminary toxicity studies.
Matesanz AI; Perles J; Souza P
Dalton Trans; 2012 Oct; 41(40):12538-47. PubMed ID: 22955178
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro pharmacological behavior of platinum(II) complexes containing 1,2-diamino-1-(4-fluorophenyl)-2-alkanol ligands.
Würtenberger I; Angermaier B; Kircher B; Gust R
J Med Chem; 2013 Oct; 56(20):7951-64. PubMed ID: 24050157
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of fluorophore-tethered platinum complexes to monitor the fate of cisplatin analogs.
Jagodinsky JC; Sulima A; Cao Y; Poprawski JE; Blackman BN; Lloyd JR; Swenson RE; Gottesman MM; Hall MD
J Biol Inorg Chem; 2015 Oct; 20(7):1081-95. PubMed ID: 26323351
[TBL] [Abstract][Full Text] [Related]
20. An in vivo highly antitumor-active tetrazolato-bridged dinuclear platinum(II) complex largely circumvents in vitro cisplatin resistance: two linkage isomers yield the same product upon reaction with 9-ethylguanine but exhibit different cytotoxic profiles.
Uemura M; Suzuki T; Nishio K; Chikuma M; Komeda S
Metallomics; 2012 Jul; 4(7):686-92. PubMed ID: 22473092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
